|
Iowa Oncology Research Association
|
3U10CA035101-28S1
|
$123,717
|
BEHRENS, ROBERT
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
3U10CA063844-20S1
|
$100,152
|
BERENBERG, JEFFREY
|
UNIVERSITY OF HAWAII AT MANOA
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$674,875
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA016087-34S2
|
$75,000
|
CARROLL, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Cancer Center Support Grant
|
3P30CA016087-34S3
|
$134,749
|
CARROLL, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Cancer Center Support Grant
|
5P30CA016087-34
|
$2,352,696
|
CARROLL, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
A Bayesian Framework for Inter-Modality Deformable Image Registration Evaluation
|
7K01CA181292-02
|
$119,534
|
CASTILLO, RICHARD
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$446,509
|
Daar, Ira
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$446,509
|
Daar, Ira
|
CCR (NCI)
|
|
Improving the Clinical Effectiveness and Understanding of the Biophysical Basis
|
2U19CA021239-35
|
$2,343,081
|
DELANEY, THOMAS
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Nevada Cancer Research foundation-Community Clinical Oncology Program
|
3U10CA035421-30S1
|
$113,166
|
ELLERTON, JOHN
|
SOUTHERN NEVADA CANCER RESEARCH FDN
|
|
Bay Area Tumor Institute CCOP
|
3U10CA045461-24S1
|
$81,028
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Ochsner Community Clinical Oncology Program
|
3U10CA035272-29S1
|
$93,960
|
FULORIA, JYOTSNA
|
OCHSNER CLINIC FOUNDATION
|
|
GHSU Minority-Based Community Clinical Oncology Program
|
3U10CA107586-10S1
|
$4,322
|
GHAMANDE, SHARAD
|
GEORGIA REGENTS UNIVERSITY
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
2P30CA021765-35
|
$5,765,603
|
GILBERTSON, RICHARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
3P30CA021765-35S1
|
$75,000
|
GILBERTSON, RICHARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
An Investigation of Radial Glia as the Source of Ependymoma Stem Cells
|
5R01CA129541-08
|
$312,849
|
GILBERTSON, RICHARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Geisinger Clinical Oncology Program
|
3U10CA035448-29S2
|
$83,066
|
GORAK, EDWARD
|
GEISINGER CLINIC
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$333,231
|
Gottesman, Michael
|
CCR (NCI)
|
|
Brain Tumor Clinical and Clinical Research Program
|
ZID BC 011098
|
$1,466,142
|
Gress, Ronald
|
CCR (NCI)
|
|
Delaware/Christiana Care Community Clinical Oncology Program
|
3U10CA045418-27S1
|
$237,321
|
GRUBBS, STEPHEN
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
00000000; D.GUY; SEVERABLE OPERATIONS FOR NCI-FREDERICK
|
261200800001E
|
$296,673,020
|
Heimbrook, David
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
St. Vincent Hospital Regional Cancer Center CCOP
|
3U10CA095968-12S1
|
$139,195
|
JASLOWSKI, ANTHONY
|
ST. VINCENT HOSPITAL
|
|
Exploration of Activity of RAD001 in vivo in Vestibular Schwannomas and Meningiom
|
5R01CA164295-03
|
$278,247
|
KARAJANNIS, MATTHIAS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-40S1
|
$74,978
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
5P30CA014236-40
|
$5,552,106
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
ATM, REACTIVE OXYGEN, AND CELLULAR RESPONSES TO HYPOXIA
|
5R01CA157216-05
|
$252,801
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Pediatric Cancer, Family Conflict and Child Adjustment
|
5R01CA134794-05
|
$281,660
|
KATZ, LYNN
|
UNIVERSITY OF WASHINGTON
|
|
Columbia University Medical Center Minority-Based Community Clinical Oncology Pro
|
3U10CA167791-02S1
|
$73,416
|
KELLY, KARA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$787,265
|
Khan, Javed
|
CCR (NCI)
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
ZIA BC 004517
|
$1,031,898
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
Sulfatide-reactive type II NKT cells: repertoire and function
|
5R01CA100660-10
|
$339,078
|
KUMAR, VIPIN
|
TORREY PINES INST FOR MOLECULAR STUDIES
|
|
EORTC HEADQUARTERS
|
5U10CA011488-44
|
$155,961
|
LACOMBE, DENIS
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
South Texas Pediatric Minority Based CCOP
|
3U10CA052771-23S1
|
$52,916
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$506,830
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,013,660
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$760,245
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Oklahoma CCOP
|
3U10CA045459-27S1
|
$68,190
|
LOCKHART, JAMES
|
WARREN CANCER RESEARCH FOUNDATION
|
|
Role of Brachyury in regulating notochord development and neoplasia
|
ZIA BC 011121
|
$88,191
|
Mackem, Susan
|
CCR (NCI)
|
|
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors
|
5R01CA122617-09
|
$250,558
|
MANNING, BRENDAN
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Nanomaterials for Cancer Diagnostics and Therapeutics
|
5U54CA151880-05
|
$2,190,152
|
MIRKIN, CHAD
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Duluth Community Clinical Oncology Program
|
3U10CA035269-30S1
|
$111,679
|
NIKCEVICH, DANIEL
|
ESSENTIA INSTITUTE OF RURAL HEALTH
|
|
GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM
|
3U10CA035178-30S1
|
$219,652
|
PADULA, GILBERT
|
SPECTRUM HEALTH HOSPITALS
|
|
Marshfield Clinic Community Clinical Oncology Program
|
3U10CA035412-30S1
|
$143,301
|
REDING, DOUGLAS
|
MARSHFIELD CLINIC RESEARCH FOUNDATION
|
|
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma
|
ZIA BC 010539
|
$27,911
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Molecular Mechanisms of Proliferation and Infiltration of MPNST and Astrocytoma
|
ZIA BC 010540
|
$55,823
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Development of Mouse Neurofibromatosis Model for Preclinical Testing
|
ZIA BC 010541
|
$195,380
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-12S2
|
$129,070
|
ROBERTSON, JOHN
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
New Mexico Minority Based Community Clinical Oncology Program
|
3U10CA086780-14S1
|
$129,683
|
ROYCE, MELANIE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Nemours Community Clinical Oncology Program
|
3U10CA176879-01S1
|
$89,460
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|